HRT Financial’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

HRT Financial’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,980	Closed	-$1.61M	–	3648
2023 Q1	$1.61M	Buy	+66,980	New	+$841K	0.02%	710
2022 Q3	–	Sell	-45,043	Closed	-$180K	–	3762
2022 Q2	$180K	Buy	+45,043	New	+$214K	﹤0.01%	2279

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HRT Financial's PRVB Position: Q2 2023 in Review

HRT Financial sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 66,980 shares — an estimated $1.61M sold.

HRT Financial first reported a position in PRVB in Q2 2022 and held it in 2 quarters. The position peaked at $1.61M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

HRT Financial reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 66,980 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.61M.
HRT Financial first reported a position in Provention Bio, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
HRT Financial's Provention Bio, Inc. Common Stock position peaked at $1.61M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.